osimertinib,lazertinib,amivantamab-vmjw
oscotec,yuhan corp,astrazeneca,genmab,janssen
['lcsm,(-blcsm)', 'lazertinib', 'sclc', 'nsclc', 'chrysalis-2']
 chrysalis-2 by dr. shu: amivantinib+lazertinib in egfr-mut #nsclc ref to osi &amp; chemo heavily pretreated pts orr 33% mpfs 5.1 mos 14.8 mo no diff bet egfr ex 19 or 21 mttr 6.4 wks d/c rate 7%, ild 7% #lcsm #asco22 
Hem/Onc Fellow @HenryFordHealth | #ASCOTrainee | Former IM Resident @michiganstateu | @UJ_MED Alum | #LCSM?????? | Girl Dad???? | @realmadrid fan | ????????????